Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Hydrochloric Acid | HCID 313 | — |
| Reactant | Doxorubicin | HCID 31703 | — |
| Reactant | N-(6-Hydrazinyl-6-oxohexyl)-2-methylprop-2-enamide | HCID 71445139 | — |
| Solvent | Methanol | HCID 887 | — |
| Solvent | chloroform methanol HOAc | HCID 21866353 | — |
| Product | HCID 86636763 | HCID 86636763 | — |
Reaction Steps
6-(Methacryloylamino)hexanoylhydrazine (40 mg, 0.188 mmol) was dissolved in 6 ml of methanol at room temperature. The solution was poured into a reaction vessel in which doxorubicin.HCl (115 mg, 0.198 mmol) was placed and the suspension was stirred vigorously. 310 μl of acetic acid was added to the suspension and the reaction mixture stirred at room temperature for 24 hours. The reaction process was monitored by TLC-Silicagel 60 F254 plates (methanol:chloroform:acetic acid 2:8:1, Rf(DOX)=0.75, Rf(MA-AH-NHN=DOX)=0.9). 100 mg of copolymer 1 was then added to the homogenous reaction mixture (to bind the residual free DOX) and the reaction mixture was stirred at room temperature for another 4 hours. The product was purified from polymeric and low-molecular impurities by means of gel chromatography in a column (30 cm×3 cm) filled with Sephadex LH-20 in methanol. The filtrate was concentrated to 2 ml and the product precipitated into 30 ml of diethyl ether. The product was sucked off, washed with a small amount of diethyl ether, and vacuum dried to constant weight. The yield was 110 mg of product (79%) with the melting point of 172 to 175° C. TLC (methanol:chloroform:acetic acid 2:8:1): one stain at Rf=0.9. MALDI-TOF MS: 762 (M+Na).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08603990B2 |
|---|
| Source dataset | uspto-grants-2013_12 |
|---|
| ORD ID | ord-4ee038d854aa41dab69057bd2c3aab4d |
|---|
| Source note | uspto-grants-2013_12 |
|---|